RSS-Feed abonnieren

DOI: 10.1055/s-0043-1777300
Study on Professor Diangui Li's Medication Experience in Treating Atrophic Gastritis Concomitant with Helicobacter Pylori Infection Based on Data Mining
Autor*innen
Funding This work was supported by the National Chinese Medicine Clinical Research Base Construction Project {Science and Technology Letter of Traditional Chinese Medicine in China, No. [2018]131}, Key Research and Development Project of Ministry of Science and Technology of the People's Republic of China (2018YFC1704100, 2018YFC1704102), Science and Technology Planning Project of Hebei Provincial Administration of Traditional Chinese Medicine (2022043), and Hebei Provincial Science and Technology Planning Project (21377724D, 21377740D).
Abstract
Objective Our objective was to explore the national traditional Chinese medicine by studying master Diangui Li's medication experience in treating atrophic gastritis (AG) concomitant with Helicobacter pylori (Hp) infection based on data mining, and to provide the reference for the clinical treatment of relevant diseases.
Methods The Chinese medicine prescriptions of the patients' first visits to the Famous Doctors' Consultation Room in Hebei Provincial Hospital of Chinese Medicine from May 2019 to December 2022 were collected and frequency analysis of the Chinese herbs, association rules analysis of the Chinese herbs, and cluster analysis were conducted using the Famous Doctor Inheritance Assistance Platform.
Results A total of 188 prescriptions were collected, with 136 kinds of Chinese herbs. The highest use frequency of Chinese herbs was 185 and the lowest was 1. There were 28 kinds of Chinese herbs with high use frequency. The top 10 herbs with the high use frequency include Baihuasheshecao (Hedyotis Diffusae Herba), Huanglian (Coptidis Rhizoma), Yinchen (Artemisiae Scopariae Herba), Jigucao (Abriherba), Baishao (Paeoniae Radix Alba), Danggui (Angelicae Sinensis Radix), Banzhilian (Scutellariae Barbatae Herba), Baihe (Lilii Bulbus), Zhishi (Aurantii Immaturus Fructus), Chuanxiong (Chuanxiong Rhizoma). Chinese herbs with high frequency use are mostly heat-clearing herbs and qi-regulating herbs; the flavors of the herbs are mainly pungent, bitter, and sweet; the properties are mainly warm, cold, and neutral; the meridian tropism is mainly the spleen, liver, and stomach meridians. The core herbal medicines are Huanglian (Coptidis Rhizoma), Yinchen (Artemisiae Scopariae Herba), Baishao (Paeoniae Radix Alba), Danggui (Angelicae Sinensis Radix), etc.; the results of association rules: Jigucao (Abriherba)-Kushen (Sophorae Flavescentis Radix), Jiaogulan (Gynostemmatis Pentaphylli Rhizoma seu Herba)-Banlangen (Isatidis Radix), Huangqin (Scutellariae Radix)-Banlangen (Isatidis Radix), etc.; the results of cluster analysis showed that there were 10 clusters: (1) Yinchen (Artemisiae Scopariae Herba), Huanglian (Coptidis Rhizoma), Baihuasheshecao (Hedyotis Diffusae Herba), Banzhilian (Scutellariae Barbatae Herba), Jigucao (Abriherba); (2) Baishao (Paeoniae Radix Alba), Danggui (Angelicae Sinensis Radix), Chuanxiong (Chuanxiong Rhizoma), Wuyao (Linderae Radix); (3) Yuanhu (Corydalis Rhizoma), Danshen (Salviae Miltiorrhizae Radix et Rhizoma), Baizhi (Angelicae Dahuricae Radix).
Conclusions For the treatment of AG concomitant with Hp infection, Professor Diangui Li mainly adopts the method of clearing heat and removing the toxin, regulating qi and resolving phlegm, combining disease differentiation with syndrome differentiation, performing reinforcing method, and reducing method simultaneously to regulate the mechanism of the human body.
CRediT Authorship Contribution Statement
X.F. was responsible for conceptualization, project administration, and supervision. D.L. was responsible for resources and funding acquisition. Y.T. was responsible for data curation and formal analysis. J.W. was responsible for the investigation and methodology. Z.S. was responsible for the investigation and project administration. F.Z. was responsible for validation and visualization. H.Z. was responsible for the formal analysis, investigation, visualization, and writing-original draft.
Publikationsverlauf
Eingereicht: 20. Juli 2023
Angenommen: 11. August 2023
Artikel online veröffentlicht:
28. Dezember 2023
© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 de Brito BB, da Silva FAF, Soares AS. et al. Pathogenesis and clinical management of Helicobacter pylori gastric infection. World J Gastroenterol 2019; 25 (37) 5578-5589
- 2 Cai Q, Shi P, Yuan Y. et al. Inflammation-associated senescence promotes Helicobacter pylori-induced atrophic gastritis. Cell Mol Gastroenterol Hepatol 2021; 11 (03) 857-880
- 3 Zhang SS, Tang XD, Huang SP. et al. Consensus on the diagnosis and treatment of chronic gastritis with Chinese medicine (2017). Zhonghua Zhongyiyao Zazhi 2017; 32 (07) 3060-3064
- 4 Chinese Pharmacopoeia Commission. Pharmacopoeia of the People's Republic of China. Beijing: China Medical Science and Technology Press; 2020
- 5 Zhong GS. Science of Chinese Pharmacology. Beijing: China Press of Traditional Chinese Medicine Co., Ltd.; 2016
- 6 Cai JD, Su HS, Hong QC. et al. Relationship between the expression of virulence genes of helicobacter pylori cag A, vac A, ice A and chronic atrophic gastritis. Chin J Noscom 2023; 33 (01) 27-30
- 7 Mao YX, Liu QM, Du PL. et al. Relevant symptoms of chronic atrophic gastritis with syndrome of turbid toxin accumulating in the stomach. Hebei Chin Med 2022; 44 (07) 1061-1064
- 8 Zhang NS. Li Dongyuan's Medical Encyclopedia (2nd edition). Beijing: China Press of Traditional Chinese Medicine Co., Ltd.; 2015
- 9 Wu F, Chen C, Peng F. Potential association between asthma, Helicobacter pylori infection, and gastric cancer. Front Oncol 2021; 11: 630235
- 10 Muluye RA, Bian Y, Alemu PN. Anti-inflammatory and antimicrobial effects of heat-clearing Chinese herbs: a current review. J Tradit Complement Med 2014; 4 (02) 93-98
- 11 Xu LK. An analysis of treating gastralgia with the Modified Baihe Wuyao Decocyion. Clinical J Chin Med 2019; 11: 50-52
- 12 Wang J, Li BL, Cai YR. et al. Discussion of the treatment thoughts on Helicobacter pylori by traditional Chinese medicine master LI Dian-Gui based on the turbidity theory. Zhonghua Zhongyiyao Zazhi 2021; 36 (08) 4627-4631
- 13 Zhang ZJ. Synopsis of Golden Chamber. Beijing: People's Medical Publishing House; 2005
- 14 Zhang XJ, Zhao LY, Li JH. et al. Research review on Zhishi (Aurantii Immaturus Fructus). Acta Chin Med Pharmacol 2021; 49 (01) 94-100
- 15 Hou W, Xu J. Research progress of the pharmacological action of Xiangfu (Cyperi Rhizoma) in different physiological systems in human body. Sichuan Chin Med 2022; 01: 213-216
